Lindsey Rolfe's Net Worth
$2.16 Million
Who is Lindsey Rolfe?
Lindsey Rolfe has an estimated net worth of $2.16 Million. This is based on reported shares across multiple companies, which include Clovis Oncology, Inc., Atreca, Inc., and CERO THERAPEUTICS HOLDINGS, INC..
SEC CIK
Lindsey Rolfe's CIK is 0001650504
Past Insider Trading and Trends
2020 was Lindsey Rolfe's most active year for acquiring shares with 20 total transactions. Lindsey Rolfe's most active month to acquire stocks was the month of February. 2020 was Lindsey Rolfe's most active year for disposing of shares, totalling 37 transactions. Lindsey Rolfe's most active month to dispose stocks was the month of November. 2020 saw Lindsey Rolfe paying a total of $127,495.20 for 171,519 shares, this is the most they've acquired in one year. In 2017 Lindsey Rolfe cashed out on 20,660 shares for a total of $440,858.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Clovis Oncology, Inc. No price found
See RemarksLindsey Rolfe owns 113,691 units of Common Stock. In the year 2015 Lindsey Rolfe filed a total of 54 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +3.75% | 4.11K |
$0.98 | -$4,188.14 | 113.69K |
Nov 1 - Nov 2
| |||
Form 4
| +2.35% | 2.52K |
$1.20 | -$3,054.00 | 109.58K |
Sep 1 - Sep 2
| |||
Form 4
| +3.93% | 4.04K |
$1.46 | -$6,325.70 | 107.06K |
Aug 1 - Aug 2
| |||
Form 4
| +2.40% | 2.41K |
$0.64 | -$1,702.62 | 103.02K |
Jun 1 - Jun 2
| |||
Form 4
| +4.27% | 4.12K |
$1.97 | -$8,375.59 | 100.6K |
May 1 - May 2
| |||
Form 4
| +11.55% | 9.99K |
$1.87 | -$20,423.37 | 96.48K |
Mar 1 - Mar 2
| |||
Form 4
| +4.67% | 3.86K |
$1.94 | -$8,755.60 | 86.49K |
Feb 1 - Feb 2
| |||
Form 4
| +0.41% | 341 |
$3.00 | -$1,038.00 | 82.63K |
Dec 1 - Dec 2
| |||
Form 4
| +5.33% | 4.17K |
$4.55 | -$19,150.95 | 82.29K |
Nov 1 - Nov 2
| |||
Form 4
| +0.44% | 341 |
$4.89 | -$1,696.83 | 78.12K |
Sep 1 - Sep 2
| |||
Form 4
| +5.68% | 4.18K |
$4.82 | -$20,219.90 | 77.78K |
Aug 1 - Aug 3
| |||
Form 4
| +0.50% | 365 |
$5.63 | -$1,812.86 | 73.6K |
Jun 1 - Jun 3
| |||
Form 4
| +5.58% | 3.87K |
$5.54 | -$24,935.54 | 73.24K |
May 1 - May 4
| |||
Form 4
| +0.95% | 652 |
$6.29 | -$4,157.69 | 69.36K |
Mar 1 - Mar 2
| |||
Form 4
| +17.91% | 10.44K |
$7.97 | -$94,149.61 | 68.71K |
Feb 1 - Feb 2
| |||
Form 4
| +3.02% | 1.71K |
$5.68 | -$9,815.04 | 58.27K |
Dec 21
| |||
Form 4
| +5.77% | 3.09K |
$4.20 | -$15,771.35 | 56.56K |
Dec 15
| |||
Form 4
| +1.23% | 651 |
$4.89 | -$3,232.29 | 53.48K |
Dec 3
| |||
Form 4
| +3.59% | 1.83K |
$4.93 | -$9,465.60 | 52.83K |
Nov 3
| |||
Form 4
| +3.43% | 1.69K |
$6.85 | -$11,967.16 | 51K |
Sep 21
| |||
Form 4
| +1.41% | 685 |
$5.30 | -$3,328.40 | 49.31K |
Sep 3
| |||
Form 4
| +3.96% | 1.85K |
$5.92 | -$11,242.08 | 48.62K |
Aug 3
| |||
Form 4
| +3.79% | 1.71K |
$6.74 | -$11,646.72 | 46.77K |
Jun 22
| |||
Form 4
| +1.42% | 632 |
$7.03 | -$4,780.40 | 45.06K |
Jun 3
| |||
Form 4
| +4.89% | 2.07K |
$8.10 | -$13,583.70 | 44.43K |
May 5
| |||
Form 4
| +17.48% | 6.3K |
$4.94 | -$42,839.68 | 42.36K |
Apr 6
| |||
Form 4
| +4.98% | 1.71K |
$4.60 | -$7,948.80 | 36.06K |
Mar 20
| |||
Form 4
| +1.86% | 626 |
$7.20 | -$4,946.40 | 34.35K |
Mar 3
| |||
Form 4
| +28.57% | 7.49K |
$8.41 | -$63,100.23 | 33.72K |
Feb 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 31
| |||
Form 4
| +6.97% | 1.71K |
$11.30 | -$19,537.70 | 26.23K |
Dec 20
| |||
Form 4
| +2.67% | 638 |
$14.60 | -$9,840.72 | 24.52K |
Dec 3
| |||
Form 4
| +7.63% | 1.69K |
$4.80 | -$8,371.20 | 23.88K |
Sep 20
| |||
Form 4
| +2.77% | 597 |
$5.21 | -$3,730.36 | 22.19K |
Sep 4
| |||
Form 4
| +8.60% | 1.71K |
$14.70 | -$25,401.60 | 21.59K |
Jun 20
| |||
Form 4
| +3.42% | 657 |
$15.07 | -$9,870.85 | 19.88K |
Jun 4
| |||
Form 4
| +9.75% | 1.71K |
$26.13 | -$45,178.77 | 19.22K |
Mar 20
| |||
Form 4
| +10.36% | 1.64K |
$29.29 | -$50,700.99 | 17.52K |
Mar 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 1
| |||
Form 4
| +12.07% | 1.71K |
$17.72 | -$30,620.16 | 15.87K |
Dec 20
| |||
Form 4
| +2.47% | 341 |
$21.23 | -$6,029.32 | 14.16K |
Dec 4
| |||
Form 4
| +14.11% | 1.71K |
$32.21 | -$55,658.88 | 13.82K |
Sep 20
| |||
Form 4
| +2.57% | 304 |
$35.75 | -$11,475.75 | 12.11K |
Sep 5
| |||
Form 4
| +16.93% | 1.71K |
$45.75 | -$79,056.00 | 11.81K |
Jun 20
| |||
Form 4
| +3.16% | 309 |
$47.70 | -$15,073.20 | 10.1K |
Jun 6
| |||
Form 4
| +21.15% | 1.71K |
$56.75 | -$98,064.00 | 9.79K |
Mar 20
| |||
Form 4
| +18.13% | 1.24K |
$58.43 | -$73,621.80 | 8.08K |
Mar 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 1
| |||
Form 4
|
∞
| 6.84K |
$63.80 | -$440,858.00 | 6.84K |
Dec 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 19
| |||
Form 4
|
—
|
0
|
$50.55 | -$379,743.86 |
0
|
Scheduled
|
Oct 28
| ||
Form 4
|
—
|
0
|
$48.06 | -$359,839.15 |
0
|
Scheduled
|
Oct 5
| ||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Atreca, Inc. (BCEL) Snapshot price: $0.068
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 22
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
CERO THERAPEUTICS HOLDINGS, INC. (PBAX) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||